Chey W - Search Results

1

Measuring response in the gastrointestinal tract in systemic sclerosis.

Khanna D, Nagaraja V, Gladue H, Chey W, Pimentel M, Frech T. Khanna D, et al. Among authors: chey w. Curr Opin Rheumatol. 2013 Nov;25(6):700-6. doi: 10.1097/01.bor.0000434668.32150.e5. Curr Opin Rheumatol. 2013. PMID: 24047604 Free PMC article. Review.

2

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. Pimentel M, et al. N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409. N Engl J Med. 2011. PMID: 21208106 Free article. Clinical Trial.

3

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials.

Schoenfeld P, Pimentel M, Chang L, Lembo A, Chey WD, Yu J, Paterson C, Bortey E, Forbes WP. Schoenfeld P, et al. Among authors: chey wd. Aliment Pharmacol Ther. 2014 May;39(10):1161-8. doi: 10.1111/apt.12735. Epub 2014 Apr 3. Aliment Pharmacol Ther. 2014. PMID: 24697851 Free PMC article.

4

Impact of National Institutes of Health Gastrointestinal PROMIS Measures in Clinical Practice: Results of a Multicenter Controlled Trial.

Almario CV, Chey WD, Khanna D, Mosadeghi S, Ahmed S, Afghani E, Whitman C, Fuller G, Reid M, Bolus R, Dennis B, Encarnacion R, Martinez B, Soares J, Modi R, Agarwal N, Lee A, Kubomoto S, Sharma G, Bolus S, Spiegel BM. Almario CV, et al. Am J Gastroenterol. 2016 Nov;111(11):1546-1556. doi: 10.1038/ajg.2016.305. Epub 2016 Aug 2. Am J Gastroenterol. 2016. PMID: 27481311 Free PMC article. Clinical Trial.

5

Nutrition in the management of gastrointestinal diseases and disorders: the evidence for the low FODMAP diet.

Eswaran S, Farida JP, Green J, Miller JD, Chey WD. Eswaran S, et al. Curr Opin Pharmacol. 2017 Dec;37:151-157. doi: 10.1016/j.coph.2017.10.008. Epub 2017 Nov 20. Curr Opin Pharmacol. 2017. PMID: 29156449 Review.

6

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.

Fodor AA, Pimentel M, Chey WD, Lembo A, Golden PL, Israel RJ, Carroll IM. Fodor AA, et al. Gut Microbes. 2019;10(1):22-33. doi: 10.1080/19490976.2018.1460013. Epub 2018 Jul 18. Gut Microbes. 2019. PMID: 29708822 Free PMC article. Clinical Trial.

7

Burden of Gastrointestinal Symptoms in the United States: Results of a Nationally Representative Survey of Over 71,000 Americans.

Almario CV, Ballal ML, Chey WD, Nordstrom C, Khanna D, Spiegel BMR. Almario CV, et al. Am J Gastroenterol. 2018 Nov;113(11):1701-1710. doi: 10.1038/s41395-018-0256-8. Epub 2018 Oct 15. Am J Gastroenterol. 2018. PMID: 30323268 Free PMC article.

8

ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. Lacy BE, et al. Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036. Am J Gastroenterol. 2021. PMID: 33315591

9

Fiber and functional gastrointestinal disorders.

Eswaran S, Muir J, Chey WD. Eswaran S, et al. Am J Gastroenterol. 2013 May;108(5):718-27. doi: 10.1038/ajg.2013.63. Epub 2013 Apr 2. Am J Gastroenterol. 2013. PMID: 23545709 Review.

10

Irritable bowel syndrome: a clinical review.

Chey WD, Kurlander J, Eswaran S. Chey WD, et al. JAMA. 2015 Mar 3;313(9):949-58. doi: 10.1001/jama.2015.0954. JAMA. 2015. PMID: 25734736 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

612 results

Search Page